Health Care Experts Push For Guidelines on Annual Skin Exams for High-Risk Individuals


There is hot debate over whether full-body skin exams should be done each year to help in early detection of both non-melanoma and melanoma skin cancers.

There is hot debate over whether full-body skin exams should be done each year to help in early detection of both non-melanoma and melanoma skin cancers.

If some members of the health care industry had their way, there would be set guidelines for people who are considered at high-risk of developing the disease. However, last year, the U.S. Preventive Services Task Force (USPSTF) states that there is “insufficient evidence” to recommend them.

“We’re lagging behind other countries,” Philip Scumpia, M.D., dermatologist and dermatopathologist at UCLA Health and UCLA Jonsson Comprehensive Cancer Center, said in an interview with CURE. “Different countries — Australia, The Netherlands, Germany, New Zealand, even the United Kingdom — all have screening guidelines for different subsets of patients. It’s not acceptable if we think we have one of the best health care systems in the world.”

A group of dermatologists and oncologists published an article in Future Medicine asking the USPSTF to revise its stance on full body skin inspections. The authors stated that they disagreed with the task force’s findings and that routine body screening of high-risk individuals could help reduce skin cancer deaths.

Skin cancer is the most common of all cancers. Although melanoma accounts for only about 1 percent of skin cancers, the American Cancer Society estimates that 9,730 people will die of the disease this year alone.

High-risk populations include people who have a family or personal history of a gene mutation that makes them more predisposed to skin cancer, especially melanoma; any patient that has had a skin cancer; people who are fair-skinned, and have blonde or red hair; people who have a significant sun exposure history; and anyone who is immunocompromised. For instance, someone who has an autoimmune condition or received a transplant.

“What I am seeing is younger and younger people, despite wearing sunscreen and trying to be more protective, are still developing skin cancer,” he said. “If we wait until these people are 50 years old, they are going to have large tumors that can cause disfiguration.”

Scumpia added, “Melanoma is one of these cancers that can kill younger people. It starts to get a higher incidence in your 30s, 40s and 50s and the death rate is one of the highest at those age groups, as well.”

Although annual physical exams with a primary care physician are important for other health related matters, Scumpia says that these professionals are not trained to look for suspicious moles and other common signs of skin cancer.

Some of the symptoms include a new or unusual growth on the body or a change in an existing mole.

“A lot of times we have a person who says, ‘Oh, I just have this pink spot or this red spot, and usually my pink/red spots go away, but this one has stayed there for three to four months.’ That’s definitely something you should biopsy,” said Scumpia. “Anything that bleeds without you scratching it, anything that is dark and growing, anything that stands out. We call it the ‘ugly duckling’ sign.”

The recommended age to start having skin exams is between 35 and 75, but there are scenarios where this should start sooner, noted Scumpia.

“Let’s say you’re a 17-year-old kid who plays baseball in the fall and spring, you play soccer in the summer, you’re outside all day, you have a family history and you have moles — you should get them checked,” he said.

In addition, Scumpia recommends using sunblock that is SPF 30 or higher that contains zinc and titanium because these will last longer than spray-on sunscreen.

Scumpia’s message for the USPSTF: “We need some sort of screening guidelines for at-risk patients. Once we get guidelines for these people, then we can extend it to the general population.”

Related Videos
Dr. Manisha Thakuria in an interview with CURE
Dr. Beth Goldstein in an interview with CURE
Treating Skin Cancer Panel
Dr. Anna C. Pavlick
Lorenzo G. Cohen
Dr. Jedd D. Wolchok
Multidisciplinary Approach Panel
Dr. Nicholas Sanfilippo
Dr. Erica B. Friedman